Heidi Larson on misinformation, the right exercise to reduce depression, and Breathtaking TV
Social media, and the rate at which the online world is changing, is worrying - especially the speed at which health disinformation can speed around the globe. We look to tech companies for a solution to the problems of their own making - but Heidi Larson, director of the Vaccine Confidence Project, and professor of anthropology, risk and decision science at LSHTM, joins us to explain why we should be cautious about focussing our attention there.
Next on the podcast, research just published in The BMJ looks at the efficacy of exercise at controlling depressive symptoms - but helps finally answer the key question - which ex...
Source: The BMJ Podcast - February 16, 2024 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Update on FDA ’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - January 26, 2024 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Anxiety and Depression Symptoms After the Dobbs Abortion Rights Decision
Following the Dobbs decision, females aged 18-45 years living in states with “trigger laws” that restricted access to abortion reported a greater increase in symptoms of anxiety and depression than those in states without trigger laws. JAMA Associate Editor Donald Goff, MD, speaks with editorialist Julia Steinberg, PhD, associate professor at the School of Public Health at the University of Maryland, about this topic. Related Content: Mental Health Symptoms When Abortion Access Is Restricted Anxiety and Depression Symptoms After the Dobbs Abortion Decision (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 23, 2024 Category: General Medicine Authors: JAMA Network Source Type: podcasts
JAMA Psychiatry : A Systematic Evaluation of Machine Learning –Based Biomarkers for Major Depressive Disorder
Interview with Nils R. Winter, MSc, author of A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder. Hosted by John Torous, MD, MBI. Related Content: A Systematic Evaluation of Machine Learning–Based Biomarkers for Major Depressive Disorder (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 10, 2024 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Association of Human Papillomavirus Status With Suicide Risk Among Patients With Head and Neck Cancer
Interview with Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES, author of Association of Human Papillomavirus Status With Suicide Risk Among Patients With Head and Neck Cancer. Hosted by Paul C. Bryson, MD, MBA. American Foundation for Suicide Prevention (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 28, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
BP Targets After Stroke Thrombectomy, Psilocybin for Depression, Large Language Models in Medicine, and more
Editor’s Summary by Anthony Charles, MD, MPH, Associate Editor of JAMA, the Journal of the American Medical Association, for the September 5, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - September 5, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Psilocybin for Major Depressive Disorder
In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, speaks with author Charles L. Raison, MD, from the Usona Institute, about the study, as well as Rachel Yehuda, PhD, Mount Sinai School of Medicine, who wrote an accompanying editorial about the potential benefits of psychedelic therapies. Related Content: Single-Dose Psilocybin Treatment for Major Depressive Disorder Psychedelic Therapy—A New Paradigm of Care for Mental Health (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - August 31, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
DAPT vs tPA for Minor Stroke, Transgender Identity and Suicide, Screening for Anxiety, and more
Editor’s Summary by Karen E. Lasser, MD, MPH, Senior Editor of JAMA, the Journal of the American Medical Association, for the June 27, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 27, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
USPSTF Recommendations: Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults
Interview with Michael Silverstein, MD, MPH, USPSTF chair and coauthor of Screening for Depression and Suicide Risk in Adults, and Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statements. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Anxiety Screening Depression and Suicide Risk Screening Screening for Depression and Suicide Risk in Adults Screening for Anxiety Disorders in Adults Screening for Depression and Suicide Risk in Adults Screening for Anxiety Disorders in Adults Are There Reasons to Fear Anxiety Screening? Reframing the Key Q...
Source: JAMA Author Interviews - June 23, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Intervention to Promote Goals-of-Care Discussions, VKA Use and Postthrombectomy Hemorrhage Risk, USPSTF on Screening for Depression and Suicide Risk, and more
Editor’s Summary by Kristin Walter, MD, MS, Senior Editor of JAMA, the Journal of the American Medical Association, for the June 20, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 20, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
What IBM's result means for quantum computing
In this episode:00:47 How to make quantum computers ready for real world applicationsQuantum computers have long held the promise of being able to perform tasks that classical computers can’t. However, despite this promise, there have been few applications that can only be accomplished by a quantum computer. Now though, researchers show that a quantum computer can resolve a physics problem concerning the orientation of quantum particles in a 2D material, which is difficult to accomplish with a ‘regular’ machine. They hope that this shows how quantum computers could be applied in real world research applications in th...
Source: Nature Podcast - June 14, 2023 Category: Science Authors: Springer Nature Limited Source Type: podcasts
TWiV 1014: Clinical update with Dr. Daniel Griffin
In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagu...
Source: This Week in Virology - MP3 Edition - June 10, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
JAMA Psychiatry : Cannabis Use Disorder and Subsequent Risk of Unipolar Depression and Bipolar Disorder
Interview with Carsten Hjorthøj, PhD, author of Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder. Hosted by John Torous, MD, MBI. Related Content: Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 24, 2023 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Bacterial ‘syringes’ could inject drugs directly into human cells
00:48 Tiny syringes for drug deliveryA team of researchers have repurposed tiny syringe-like structures produced by some bacteria to deliver molecules directly into human cells. They hope that this method could be used to overcome a big challenge in modern medicine, namely ensuring that therapeutics are delivered into the precise cells that need to be treated.Research article: Kreitz et al.News and Views: Mix-and-match tools for protein injection into cells07:05 Research HighlightsA diamond-like material could protect spacecraft from intense radiation, and how gene editing could help in the treatment of a rare genetic cond...
Source: Nature Podcast - March 29, 2023 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Trends in Pediatric Mental Health Hospitalizations
Mary Arakelyan, MPH, and JoAnna Leyenaar, MD, PhD, MPH, vice chair of Research in Pediatrics at Dartmouth, discuss increases in pediatric mental health hospitalizations and suicide-related diagnoses over the past decade. Hosted by JAMA Associate Editor Tracy Lieu, MD, MPH. Related Content: Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019. Related Content: Pediatric Mental Health Hospitalizations at Acute Care Hospitals in the US, 2009-2019 (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - March 28, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
